Health

#SFHS2612378ARenewal of French reimbursement listing for MEPILEX heel and sacrum wound dressings

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This order keeps several MÖLNLYCKE MEPILEX high-absorption foam dressings on France’s reimbursable products list and updates their listing details. The covered products include MEPILEX Talon, MEPILEX BORDER PROTECT Talon, and MEPILEX BORDER PROTECT Sacrum in specified sizes and pack formats. Hospitals, pharmacies, prescribers, wound-care teams, and patients using these dressings are affected. Reimbursement remains available for covered acute wounds and certain chronic wounds from the granulation phase, especially in hard-to-dress areas such as the heel and sacrum, until 1 September 2030.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Renews reimbursement coverage for specified MEPILEX heel and sacrum foam dressings until 1 September 2030
  • Updates the reimbursable product listing for MÖLNLYCKE HEALTH CARE France in the French products and services reimbursement list
  • Confirms covered indications for acute wounds and certain chronic wounds in hard-to-dress areas such as the heel and sacrum

Obligations

What this law requires

medium

Reimbursement coverage for MEPILEX Talon dressings must be limited to the listed indications: treatment of acute wounds regardless of phase, and sequential treatment of chronic wounds from the granulation phase when located in difficult-to-dress areas such as the heel.

healthcare prescriberspharmacieshospitalswound-care teamsreimbursement administrators
Coverage ends on 1 September 2030
operational
medium

Only the specified MEPILEX Talon reimbursable references may be supplied or billed under the LPPR listing: 210 cm² boxes of 10 and 5, and 255 cm² boxes of 10 and 5, with the stated reference codes.

pharmacieshospitalsmedical device suppliersreimbursement administrators
Coverage ends on 1 September 2030
operational
medium

Reimbursement coverage for MEPILEX BORDER PROTECT Talon dressings must be limited to the listed indications: treatment of acute wounds regardless of phase, and sequential treatment of chronic wounds from the granulation phase when located in difficult-to-dress areas such as the heel.

healthcare prescriberspharmacieshospitalswound-care teamsreimbursement administrators
Coverage ends on 1 September 2030
operational
medium

Only the specified MEPILEX BORDER PROTECT Talon reimbursable references may be supplied or billed under the LPPR listing: 398 cm² boxes of 10 and 5, with the stated reference codes.

pharmacieshospitalsmedical device suppliersreimbursement administrators
Coverage ends on 1 September 2030
operational
medium

Reimbursement coverage for MEPILEX BORDER PROTECT Sacrum dressings must be limited to the listed indications: treatment of acute wounds regardless of phase, and sequential treatment of chronic wounds from the granulation phase when located in difficult-to-dress areas such as the sacrum.

healthcare prescriberspharmacieshospitalswound-care teamsreimbursement administrators
Coverage ends on 1 September 2030
operational

Affected Parties

MÖLNLYCKE HEALTH CARE FranceHospitals and wound-care providers+2 more…

Tags

medical devices,reimbursement,wound care…